Prior studies reported that Myeloperoxidase and Galectin-3, which are biomarkers of coronary plaque vulnerability, are elevated in acute coronary syndrome (ACS) patients. We studied the temporal evolution of these biomarkers… Click to show full abstract
Prior studies reported that Myeloperoxidase and Galectin-3, which are biomarkers of coronary plaque vulnerability, are elevated in acute coronary syndrome (ACS) patients. We studied the temporal evolution of these biomarkers early after ACS admission and prior to a recurrent ACS event during 1 year follow-up.
Keywords:
acute coronary;
myeloperoxidase galectin;
admission;
coronary syndrome;
temporal evolution
Journal Title: American heart journal
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: American heart journal
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!